GlassScriptPhysician profile
Robert W Sessoms
NPI 1053366765
$314.79
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $76.96 · 2020: $207 · 2021: $15.88 · 2022: $14.52.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $61.14 | 2019-2020 | |
| Orexo US, INC. | $38.79 | 2020 | |
| Indivior INC. | $36.52 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $30.71 | 2020 | |
| Mdd US Operations, LLC | $20.71 | 2020 | |
| Amgen INC. | $20.01 | 2019 | |
| Scilex Pharmaceuticals INC. | $18.06 | 2020 | |
| Amarin Pharma, INC. | $16.03 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $15.88 | 2021 | |
| Biodelivery Sciences International, INC. | $15.36 | 2020 | |
| Ucb, INC. | $14.46 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $13.96 | 2020 | |
| Avanir Pharmaceuticals, INC. | $13.16 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Sessoms listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.